Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA447802
Max Phase: Preclinical
Molecular Formula: C35H64O6
Molecular Weight: 580.89
Molecule Type: Small molecule
Associated Items:
ID: ALA447802
Max Phase: Preclinical
Molecular Formula: C35H64O6
Molecular Weight: 580.89
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 4-Deoxyannoreticuin
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCCCCCCCCCC[C@@H](O)[C@H]1CC[C@H]([C@H](O)CCCCCC(O)CCCCCCC2=C[C@H](C)OC2=O)O1
Standard InChI: InChI=1S/C35H64O6/c1-3-4-5-6-7-8-9-10-11-18-23-31(37)33-25-26-34(41-33)32(38)24-19-14-17-22-30(36)21-16-13-12-15-20-29-27-28(2)40-35(29)39/h27-28,30-34,36-38H,3-26H2,1-2H3/t28-,30?,31+,32+,33+,34+/m0/s1
Standard InChI Key: JHKNWORCLXKZFL-GCIOFLGLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 580.89 | Molecular Weight (Monoisotopic): 580.4703 | AlogP: 8.09 | #Rotatable Bonds: 26 |
Polar Surface Area: 96.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.39 | CX Basic pKa: | CX LogP: 9.09 | CX LogD: 9.09 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.07 | Np Likeness Score: 1.75 |
1. Alali FQ, Liu XX, McLaughlin JL.. (1999) Annonaceous acetogenins: recent progress., 62 (3): [PMID:10096871] [10.1021/np980406d] |
2. Yang H, Zhang N, Li X, Chen J, Cai B.. (2009) Structure-activity relationships of diverse annonaceous acetogenins against human tumor cells., 19 (8): [PMID:19285863] [10.1016/j.bmcl.2009.02.105] |
3. Chen Y, Chen JW, Xu SS, Wang Y, Li X, Cai BC, Fan NB.. (2012) Antitumor activity of annonaceous acetogenins in HepS and S180 xenografts bearing mice., 22 (8): [PMID:22446092] [10.1016/j.bmcl.2012.02.109] |
Source(1):